Organic Process Research and Development p. 167 - 175 (2001)
Update date:2022-09-26
Topics:
Roche, Didier
Sans, David
Girgis, Michael J.
Prasad, Kapa
Repic, Oljan
Blacklock, Thomas J.
The need for an economical process for producing 2-aminoindan hydrochloride, a key starting material in manufacturing novel bioactive molecules, motivated development of a novel synthetic route using an inexpensive reactant, ninhydrin. The synthesis, involving oximation of ninhydrin followed by catalytic reduction of the resulting oxime intermediate to give 2-aminoindan, was demonstrated successfully, and a product purification scheme was developed to isolate 2-aminoindan as the hydrochloride salt form. Subsequent process development optimized the reduction step by identifying regimes of fast and slow reaction (corresponding to reduction of oxime and diketone functions, respectively), and tailoring reaction conditions to use mild conditions during the fast exothermic regime to ensure process safety followed by more severe conditions for the slower reaction. The process was successfully scaled up 100-fold in a pilot plant, with excellent yield and product quality agreement between laboratory and pilot plant.
View MoreXINXIANG AURORA BIOTECHNOLOGY CO., LTD.
website:http://www.aurora-biotech.com
Contact:86-373-3088722
Address:No. 348, Pingyuan Road, Xinxiang City, Henan Province, China
website:http://www.wondapharm.com
Contact:86-027-84306245
Address:Wuhan Private Science and Technology Park , Wuhan, China
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Changyi Xinxing Technology Development Co., Ltd.
Contact:0086-510-86651065(Time Zone:8),86651656
Address:94 Yingbinxilu WestRoad, Huangtu Town, Jiangyin City, Jiangsu, China
Chongqing Werlchem Fine Chemical Co. Ltd
Contact:+86-23-67521957
Address:NO.15,Fortune Road,Yubei District,401121,Chongqing,China
Doi:10.1021/om0110078
(2002)Doi:10.1021/ol0172368
(2002)Doi:10.1021/acscatal.8b02029
(2018)Doi:10.1016/S0031-9422(00)86972-1
(1983)Doi:10.1055/s-0037-1610662
(2019)Doi:10.1016/j.tetasy.2005.12.022
(2006)